XML 47 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Contrave Acquisition (Table)
9 Months Ended
Sep. 30, 2017
Business Combinations [Abstract]  
Estimated Fair Value of Total Consideration

The estimated fair value of the total consideration at the date of acquisition (August 1, 2016) is as follows (in thousands):

 

Prepaid purchase price payment to Takeda in March 2016

 

$

60,000

 

Fair value of contingent consideration due to Takeda

 

 

18,800

 

Payment due to Takeda for Contrave inventory

 

 

7,762

 

Estimated payment due to Takeda for charge-backs and rebates

 

 

823

 

Cash received from Takeda for estimated returns as of August 1, 2016

 

 

(1,667

)

Total Purchase Price

 

$

85,718

 

 

Summary of Purchase Price Allocation

The allocation as of the date of the acquisition is as follows (in thousands):

 

Developed technology intangible

 

$

74,967

 

Tradename

 

 

4,400

 

Inventory

 

 

14,261

 

Assumption of accrued expenses (savings card program)

 

 

(5,687

)

Assumption of accrued expenses (returns reserve)

 

 

(2,223

)

Total Fair Value of Assets Acquired and Liabilities Assumed

 

$

85,718

 

 

Remaining Estimated Amortization Expense Related to Intangible Assets

The remaining estimated amortization expense related to the intangible assets recorded in connection with the Contrave acquisition for 2017 through 2021 and thereafter is as follows (in thousands):

 

2017

 

$

1,983

 

2018

 

 

7,938

 

2019

 

 

7,938

 

2020

 

 

7,938

 

2021

 

 

7,938

 

Thereafter

 

 

36,373

 

 

 

$

70,108

 

 

Unaudited Pro Forma Financial Information

The following unaudited pro forma financial information presents results as if the acquisition of Contrave had occurred on January 1, 2016 (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Revenues

 

$

18,903

 

 

$

10,965

 

 

$

61,404

 

 

$

42,677

 

Net loss

 

 

(20,829

)

 

 

(36,040

)

 

 

(120,434

)

 

 

(147,504

)

Net loss per share - basic and diluted

 

 

(1.35

)

 

 

(2.47

)

 

 

(7.94

)

 

 

(10.12

)